The rise of high-deductible health insurance is challenging providers across the country to change the way they prepare for and collect payments from people getting hit with large out-of-pocket costs for care.
McKesson Corp. announced two deals with big-box chain Wal-Mart Stores that are expected to boost the healthcare giant after recent struggles.
Fourth-quarter and full-year earnings soared at healthcare giant McKesson Corp., mostly due to the absence of previous acquisition-related charges.
An effort to develop technology to enroll a portion of the 1 million volunteers in the White House's Precision Medicine Initiative is placing a spotlight on one possible solution to interoperability and in the meantime creating unprecedented collaboration.
McKesson Corp. is cutting its workforce by 4% or about 1,600 jobs and refining its strategy to lower costs. The plan should save the drug distributor $170 million to $190 million before taxes in fiscal 2017, as well as incremental savings of $70 million to $90 million in 2018.
Hospital systems now routinely deal with an uncomfortable number of drug shortages, so they're forging direct relationships with manufacturers, and buying directly from the source when the usual channels dry up.
One of the frustrating things about healthcare data is that they live in silos, so the user experience is far from seamless. But that's becoming unacceptable with the growth of high-deductible health plans and the corresponding wave of healthcare consumerism.
Prescription drug distributor McKesson Corp. is buying Canadian pharmacy operator Rexall Health from Katz Group for $2.2 billion, strengthening McKesson's Canadian pharmaceutical supply chain.
BlackRock, the world's largest asset manager, is placing big bets on healthcare stocks. The giant New York money manager, which oversees more than $4.5 trillion in assets, took large positions last year in at least 14 investor-owned healthcare companies and a host of medical-device and equipment...
Hospital systems that have acquired physician practices and outpatient treatment centers are wrestling with how to integrate them into their existing supply-chain distribution system. The goal is to extend the low prices achieved through bulk purchasing to these geographically dispersed facilities.
McKesson Corp. reported a profit jump in its third quarter, thanks to lower foreign taxes and growth in its North American pharmaceutical distribution and services.
Healthcare giant McKesson Corp. reported a jump in earnings in its second quarter thanks to strong distribution revenue, lower-than-expected taxes and the sale of its workplace-safety supply business.